Cargando…
Androgen receptor function and targeted therapeutics across breast cancer subtypes
Despite significant progress in breast cancer (BC) therapy, it is globally the most commonly diagnosed cancer and leads to the death of over 650,000 women annually. Androgen receptor (AR) is emerging as a potential new therapeutic target in BC. While the role of AR is well established in prostate ca...
Autores principales: | Kolyvas, Emily A., Caldas, Carlos, Kelly, Kathleen, Ahmad, Saif S. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9664788/ https://www.ncbi.nlm.nih.gov/pubmed/36376977 http://dx.doi.org/10.1186/s13058-022-01574-4 |
Ejemplares similares
-
Androgen Receptor: A Complex Therapeutic Target for Breast Cancer
por: Narayanan, Ramesh, et al.
Publicado: (2016) -
Immunohistochemical Expression of Androgen Receptors (AR) in Various Breast Cancer Subtypes
por: Ismael, Nour El Hoda S., et al.
Publicado: (2019) -
Androgen Receptor Is Expressed in the Majority of Breast Cancer Brain Metastases and Is Subtype-Dependent
por: Fan, Kevin Yijun, et al.
Publicado: (2023) -
Androgen Receptor Signaling in Prostate Cancer Genomic Subtypes
por: Jillson, Lauren K., et al.
Publicado: (2021) -
Androgen Receptor Signaling in Prostate Cancer Genomic Subtypes
por: Hussein, Mohamed Ali, et al.
Publicado: (2023)